1-(4-fluorophenyl)-3-(5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[1,2-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)urea

ID: ALA4783228

PubChem CID: 72549555

Max Phase: Preclinical

Molecular Formula: C29H31F4N9O4S

Molecular Weight: 677.69

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(NC(=O)Nc5ccc(F)cc5)cc4C(F)(F)F)nn3c2)CC1

Standard InChI:  InChI=1S/C29H31F4N9O4S/c1-47(44,45)41-8-6-39(7-9-41)17-19-14-24-27(40-10-12-46-13-11-40)37-26(38-42(24)18-19)22-16-34-25(15-23(22)29(31,32)33)36-28(43)35-21-4-2-20(30)3-5-21/h2-5,14-16,18H,6-13,17H2,1H3,(H2,34,35,36,43)

Standard InChI Key:  HJCORAKOKHFQME-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 47 52  0  0  0  0  0  0  0  0999 V2000
   28.5074  -24.6823    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3223  -24.6806    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   28.9128  -23.9735    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   21.9643  -27.9145    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   21.2557  -27.5058    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.2526  -28.3229    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.3932  -25.9025    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.0984  -25.4980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0984  -24.6808    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.3932  -24.2681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6879  -25.4980    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.6879  -24.6763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9064  -24.4223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4233  -25.0871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9063  -25.7518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3923  -23.4476    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.1090  -23.0386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1100  -22.2216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4008  -21.8083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.6888  -22.2181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6861  -23.0412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8037  -25.9066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8012  -26.7249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5075  -27.1344    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.2168  -26.7268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2153  -25.9054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5085  -25.4995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9228  -27.1387    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6061  -25.0871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1975  -25.7948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.3790  -25.7946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9705  -26.4983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3756  -27.2084    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.1937  -27.2103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6067  -26.5022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3702  -28.6238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7992  -24.2747    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.6323  -26.7334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3382  -27.1453    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.6361  -25.9162    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.0478  -26.7399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7500  -27.1527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4591  -26.7480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.4633  -25.9300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7525  -25.5182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.0463  -25.9253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1753  -25.5246    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  1  3  1  0
  5  4  2  0
  4  6  2  0
 12 10  1  0
 11  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 10 16  1  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  8 22  1  0
 25 28  1  0
 14 29  1  0
 29 30  1  0
 30 31  1  0
 30 35  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 33  4  1  0
  4 36  1  0
 27  1  1  0
  1 37  1  0
 28 38  1  0
 38 39  1  0
 38 40  2  0
 39 41  1  0
 41 42  2  0
 42 43  1  0
 43 44  2  0
 44 45  1  0
 45 46  2  0
 46 41  1  0
 44 47  1  0
M  END

Associated Targets(Human)

SJRH30 (203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CA Tclin PI3-kinase p110-alpha subunit (12269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 677.69Molecular Weight (Monoisotopic): 677.2156AlogP: 3.51#Rotatable Bonds: 7
Polar Surface Area: 137.30Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.89CX Basic pKa: 5.59CX LogP: 4.28CX LogD: 4.27
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.28Np Likeness Score: -2.01

References

1. Xiang HY,Wang X,Chen YH,Zhang X,Tan C,Wang Y,Su Y,Gao ZW,Chen XY,Xiong B,Gao ZB,Chen Y,Ding J,Meng LH,Yang CH.  (2021)  Identification of methyl (5-(6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo[2,1-f][1,2,4]triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) as an orally bioavailable, highly potent, PI3K alpha inhibitor for the treatment of advanced solid tumors.,  209  [PMID:33109399] [10.1016/j.ejmech.2020.112913]

Source